Search
Search Results
##search.searchResults.foundPlural##
-
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1339HTML: 379PDF: 808 -
Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large b-cell lymphoma.
3275PDF: 1013HTML: 989Figure 1: 167 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1141PDF: 598HTML: 6788 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4739PDF: 1739HTML: 2693Untitled: 207 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1255PDF: 603HTML: 3065 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4745PDF: 1779HTML: 2115 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3508PDF: 1465HTML: 4358CoverLetter: 180Figure1: 190 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2056PDF: 981HTML: 4057Cover Letter: 216Figure 1: 223Figure 2: 225Table 1: 200 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
1928PDF: 812HTML: 2189Table 1: 170Table 2: 191Table 3: 183Table 4: 185Table 5: 183Tble 6: 176Cover Letter: 198Greene Tab.7: 181 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2128PDF: 1555HTML: 252 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4257PDF: 1738HTML: 1099 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1816PDF: 1040HTML: 222 -
Pseudo-differentiation syndrome
1317PDF: 649HTML: 10833Figure 1: peripheral blood showing myeloblasts with auer rods: 112Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 100Figure 3: CXR showing pulmonary infiltartes with consolidation: 134Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 104Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 114 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
929PDF: 1196HTML: 97 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1152PDF: 479HTML: 207 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2035PDF: 1493HTML: 264 -
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia
1531PDF: 494HTML: 151 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2404PDF: 1281HTML: 1733CoverLetter: 171 -
THE CHALLENGE OF AML IN OLDER PATIENTS
2149PDF: 935HTML: 2147 -
-
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277612PDF: 1777HTML: 3844 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2170PDF: 935HTML: 5046Cover Letter: 163Figure 2: 155Figure 1: 167Figure 3: 188Figure 4: 163Figure Legend: 177Table 1: 182Table 2: 174Table 3: 173 -
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
2753PDF: 754HTML: 1256Blood Count trend before and during lenalidomide treatment: 166Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 181 -
-
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4631PDF: 2791HTML: 2263 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1070PDF: 832HTML: 229







